Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Sources Sought opportunity from Department Of Defense was posted on December 3, 2025. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

BATTLEFIELD WOUND INFECTION PREVENTION AND TREATMENT (BWI P&T): BARRIER COMBINATION PRODUCT DEVELOPMENT

Closed
HT9427-26-RFI-BWI-PTFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

NAICS

339113 - Surgical Appliance and Supplies Manufacturing

Place of Performance

MD, 21702, USA

Set-Aside

NONE

Documents

4

Attachment 3 - BWI PT Barrier Minimum Essential Characteristics

DOCX, High priority: read this first1 page · minimum-essential-characteristics
High

RFI HT9427-26 Attachment 2 - Company Product Information

DOC, High priority: read this first1 page · rfi
High

RFI HT9427-26-RFI-BWI-PT Battlefield Wound Infection Prevention and Treatment Barrier Product

DOCX, High priority: read this first2 pages · rfi
High

Technology Readiness Levels for Pharmaceuticals and Medical Devices

DOCX, Low priority4 pages · other
Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Sources Sought

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Health Agency
Contacts2 people available
OfficeFORT DETRICK, MD, 21702, USA
Office AddressFORT DETRICK, MD, 21702, USA
Contacts
Jeanette Collins

Full Description

Show more

The Government is conducting market research to determine whether a commercial solution can be provided to meet requirements for battlefield wound infection prevention and treatment: barrier combination product. This market research may also assist with the further development and/or refinement of the requirements.


Objective and Purpose/Scope: DHA’s OPMED WPAC has a requirement to develop, deliver, and field medical products that address battlefield wounds and subsequent bacterial and fungal infections.  The Battlefield Wound Infection Prevention and Treatment (BWI P&T) program is using a Family of Systems (FoS) approach that aims to develop multiple medical materiel solutions that are most relevant for use in austere environments where medical products may be limited and evacuation may be prolonged. 


This RFI seeks responses to the barrier combination component of this FoS only.


Although there is an emphasis on use at the point of injury, this capability will likely be used across roles


of care spanning the austere battlefield environment to hospital care settings. The barrier combination product is


expected to be one of many components of the FoS that will provide novel solutions to the DoD and commercial


market with respect to wound care and infection prevention.
 


The barrier combination product must have the following minimum essential characteristics:
 


Please refer to Attachment 3 - Minimum Essential Characteristics (MECS)


 North American Industry Classification System (NAICS) Code: Unknown


RFI Attachments: The following documents are attached to the RFI


  • Attachment 1: Technical Readiness Level (TRL) (Reference Only)
  • Attachment 2: Company & Product Information
  • Attachment 3: Minimum Essential Characteristics (MECS)


  • Response Due Date: Interested parties shall submit the RFI response electronically by 2:00pm  Eastern on January 20, 2026, via e-mail to:

Please review Attachments 1, 2, and 3 as well as RFI for BWI PT Barrier Attachment for further instructions

More opportunities from Department Of Defense → Defense Health Agency

Same awarding agency

NAICS: 811210
New
Federal
Zeiss Meditec Ophthalmology Equipment Maintenance
Solicitation # HT940627QE003
Solicitation HT940627QE003 is a Request for Quote issued by the Defense Health Agency, Healthcare Contracting Division-Southeast, for a firm-fixed-price contract to provide full-service maintenance for Zeiss MediTec ophthalmology equipment at the Naval Medical Center Camp Lejeune in North Carolina. The scope of work includes regularly scheduled preventative maintenance, timely onsite repairs, and software updates for specific devices, including the CIRRUS 5000, IOLMASTER 700, HFA3 B60, and ATLAS 900. All services must be performed according to manufacturer recommendations and applicable FDA regulations. The contract consists of a base period from December 1, 2026, to November 30, 2027, with four subsequent option periods extending the potential performance through November 30, 2031. This procurement is a total small business set-aside under NAICS code 811210. Award will be made based on the Lowest Priced Technically Acceptable (LPTA) basis, where technical capability is evaluated independently of price. Offerors must submit two separate volumes: Volume I for technical capability, which must describe the functional approach and methodology without identifying company names or logos, and Volume II for comprehensive pricing. Quotes are due by 8:00 am Eastern Time on October 29, 2026. Payment and invoicing will be processed electronically through the Wide Area WorkFlow system.
Electronic and Precision Equipment Repair and Maintenance

POSTED

1 day ago

DEADLINE

in 8 days
View Details
NAICS: 541715
New
Federal
Prototype development for Battlefield Wound Infection Prevention and Treatment (BWI P&T) Barrier Combination
Solicitation # HT9427-26-R-E020
The Defense Health Agency Contracting Activity is seeking a single award for the development of a Battlefield Wound Infection Prevention and Treatment Barrier Combination prototype. This product must integrate a physical wound barrier with antimicrobial and antifungal properties to prevent the spread of organisms and systemic infections in combat scenarios. The project aims to advance technologies from a preferred Technology Readiness Level of 5 or higher to a final state of TRL 7 or 8, culminating in mandatory U.S. Food and Drug Administration approval or clearance. The scope of work includes preclinical testing, human clinical trials, and the submission of regulatory packages such as New Drug Applications or Premarket Approval Applications. This procurement is conducted under prototype Other Transaction Authority 10 U.S.C. 4022, meaning standard FAR and DFARS regulations do not apply unless expressly referenced. The estimated period of performance is 48 months, divided into three primary objectives: prototype demonstration, clinical studies and regulatory submissions, and final FDA clearance. Proposals are due by November 6, 2026, and must be submitted in three distinct volumes covering technical approach, management capability, and administrative cost and price. To be eligible, offerors must be registered in the System for Award Management and meet specific criteria, such as being a nontraditional defense contractor or a small business.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

1 day ago

DEADLINE

in 17 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS